Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (894)	3/14/2005 1:28:24 AM
From: Jibacoa	Read Replies (1) of 3722

Re: ALXN "Close watch".<g> Although the stock remains on the downtrend coming from the Feb.8 H at 26.81 (that was below the H on Feb.4 of 26.96)it has been trying to hold above the 20 level this past week. The stock went through the "support" at 21.39 (the H on Nov.12 ) and nearest support is now the Nov.4 H at 19.40 and then the Oct.4 H at 19.20 <g> The PSML & SAR on ALXN at present: 20.32 20.63 21.87 22.97 & 22.03 (All still on a downtrend pattern). ALXN reported better revenues (273% better) on the last Q after it received new grants, but the loss is not expected to be cut further until after the close of the present fiscal year (Jul.) It has 3 PIIIs going on and of the two C5 inhibitors the one that seems to have better potential is the trial of pexelizumab that it is been carried in cooperation with PG for patients after CABGs and also AMI. If they announce good results I think we could see the stock trading at the $50 level again this year.<g> It hasn't done that since 2001 (The Mar.2000 H was 119.88 <g>) But I think I better wait to buy some until it can close above $22.<g> bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next